Puengan, Andrey G.
HRN: 13-58-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
07/03/2023
07/10/2023
IV
1%
Q12hrs
Superficial Thickness Burn
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes